Synthesis of Carbohydrate-Based Phospholipids
A R T I C L E S
of dry acetonitrile, and the reaction mixture was stirred for 7 h. Next,
an oxidizing solution of 0.1 M I2 in THF/Pyr/H2O (approximately 20
mL) was added until I2 remained. The solvent was removed via high
vacuum yielding the intermediate (4.50 g). To remove the cyanoethyl
protecting group, 0.34 g of the intermediate was dissolved in 43 mL
of 0.14 M (aq) TEA and stirred for 3 h. The TEA was removed via
high vacuum, and the remaining water was removed by lyophilization.
Purification of 5 was achieved using alumina chromatography (72/28
chloroform/methanol - 69/27/4 chloroform/methanol/H2O), Sephadex
G-10 size exclusion chromatography (50/50 chloroform/methanol), and
finally C-18 Sep Pak chromatography (10/90 methanol/chloroform).
A white solid 5 was obtained in 33.5% yield for the last three steps
(45.4 mg). 2-D COSY and HMQC spectrum were performed to assign
the resonances observed in the H NMR spectra. H NMR (CD3CN,
500 MHz, ppm): H(3), 5.205 (1H, t, J ) 5.40 Hz); H(2), 5.122 (1H,
dd, J ) 4.80 Hz); H(1), 4.868 (1H, d, J ) 1.6 Hz); H(4), 4.173 (1H,
m); CH2OP, 4.173 (1H, m); H(5), 3.848 (1H, m); H(5), 3.773 (1H, m);
CH2N+, 3.498 (2H, m); OMe, 3.345 (3H, s); N+(CH3)3, 3.144 (9H, s);
H(R), 2.284 (4H, m); H(â), 1.548 (4H, m); (CH2)n, 1.266 (m); ω CH3,
0.872 (t, 6.40 Hz).41 13C NMR (CD3CN, 125 MHz, ppm): CdO,
173.54; CdO, 173.50; C(3), 75.15; C(2), 72.53; C(1), 107.13; C(4),
81.91; CH2OP, 59.97; C(5), 59.53; CH2N+, 67.48; OMe, 55.44; N+-
(CH3)3, 54.80; C(R), 34.32; C(â), 25.401; ω CH3, 12.21; (CH2)n, 30.2
(31P NMR 0.067 ppm). High-resolution FAB mass spectrometry ((MH)+
theoretical ) 694.4659, observed ) 694.4653).
4.190 (1H, m); CH2OP, 4.190 (1H, m); H(5), 3.880 (1H, m); H(5),
3.801 (1H, m); CH2N+, 3.513 (2H, m); OMe, 3.344 (3H, s); N+(CH3)3,
3.141 (9H, s); H(R), 2.282 (4H, m); H(â), 1.542 (4H, m); (CH2)n, 1.261
(m); ω CH3, 0.871 (t, 7.2 Hz). 13C NMR (CD3CN, 100 MHz, ppm):
CdO, 173.62; CdO, 173.35; C(3), 75.12; C(2), 72.17; C(1), 107.15;
C(4), 80.97; CH2OP, 60.40; C(5), 59.20; CH2N+, 67.10; OMe, 55.75;
N+(CH3)3, 54.89; C(R), 34.52; C(â), 25.51; ω CH3, 14.39; (CH2)n, 30.65
(31P NMR 0.595 ppm). High-resolution FAB mass spectrometry ((MH+)
theoretical ) 750.5285, observed ) 750.5255).
Bis-(2,3-arachadonyl)-1-methoxy-5-hydroxy-ribose, 10. 2 (1.02 g,
6.20 mmol), arachadonic acid (6.19 g, 19.81 mmol), and DMAP (2.42
g, 6.20 mmol) were dissolved in 200 mL of dry DMF. DCC (4.09 g,
6.20 mmol) was added dropwise, and the reaction was stirred at 40 °C
for 48 h. Next, 5 mL of 5% acetic acid was added to the reaction vessel,
and the white precipitate was filtered. The resultant solution was
evaporated under high vacuum before being dissolved in CHCl3 and
washed with 0.5 N HCl, 5% NaHCO3, and water. After drying with
Na2SO4, the solution was rotoevaporated to dryness. Silica gel column
purification (9/1 Hex/EtAC) was performed. The product was dissolved
in aqueous acetic acid and stirred at 50 °C for 12 h to remove the trityl
protecting group. The deprotected product was purified by silica gel
column chromatography (9/1 Hex/EtAC - 7/3 Hex/EtAc) to afford
10 in a 36% yield (1.60 g). 1H NMR (CDCl3, 400 MHz, ppm): H(3),
5.338 (1H, t); H(2), 5.235 (1H, d); H(1), 4.887 (1H, s); H(4), 4.197
(1H, m); H(5), 3.867 (2H, m); OMe, 3.415 (3H, s); H(R), 2.332 (m);
H(â), 1.613 (m); (CH2)µ, 1.258 (m); ω CH3, 0.862 (t).
Bis-(2,3-arachadonyl)-1-methoxy-5-(phosphocholine)-ribose, 11.
10 (1.18 g, 2.46 mmol) was dissolved in 45 mL of dry CH2Cl2, and
DIPEA (0.73 mL, 4.18 mmol) was added. The reaction vessel was then
chilled to 0 °C before adding 2-cyanoethyl-N,N ′-diisopropylchloro-
phosphoramidite (0.02 mL, 3.70 mmol). The reaction was stirred for 4
h at 22 °C and subsequently evaporated under high vacuum for 1.5 h.
The crude material was dissolved in dry CH2Cl2 and then washed with
5% NaHCO3 and H2O before being dried with Na2SO4. Choline chloride
(0.49 g, 3.20 mmol) was azeotroped twice with toluene, dried under
high vacuum overnight at 45 °C, and then added to the flask containing
the intermediate. The reaction mixture was then dissolved in 94/6
CH3CN/CH2Cl2, and tetrazole (0.22 g, 3.20 mmol) was added. The
reaction was stirred for 12 h. Oxidation of the P(III) was accomplished
using I2 in THF/Pyr/H2O, and the reaction was stirred for 3 h and then
evaporated under high vacuum. The resultant mixture was dissolved
in 113 mL of H2O containing 2 mL of TEA and stirred for 3 h at 22
°C. The solvent was subsequently removed by lyophilization. To isolate
the product, the reaction mixture was first dissolved in benzene and
filtered. The benzene solution was then concentrated to a minimum
before layering with MeOH and refrigerating overnight. Next, the
resulting product was filtered from solution and purified using a G-10
size exclusion column in 50/50 CHCl3/MeOH followed by a neutral
alumina (70-230 mesh) column (72/28 CHCl3/MeOH - 69/27/4
CHCl3MeOH/H2O) to afford 0.12 g (5.2% yield) of product. 1H NMR
(CD3OD, 400 MHz, ppm): H(3), 5.353 (1H, t, J ) 5.6 Hz); H(2),
5.214 (1H, m); H(1), 4.910 (1H, m); H(4), 4.250 (1H, m); CH2OP,
4.280 (1H, m); H(5), 3.951 (1H, m); H(5), 3.951 (1H, m); CH2N+,
3.624 (2H, m); OMe, 3.390 (3H, s); N+(CH3)3, 3.212 (9H, s); H(R),
2.341 (4H, m); H(â), 1.605 (4H, m); (CH2)m, 1.295 (m); ω CH3, 0.860
(t, 7.2 Hz). 13C NMR (CD3OD, 100 MHz, ppm): CdO, 173.43; Cd
O, 173.18; C(3), 74.83; C(2), 71.81; C(1), 106.64; C(4), 80.60; CH2-
OP, 62.73; C(5), 59.30; CH2N+, 67.11; OMe, 55.507; N+(CH3)3, 54.72;
C(R), 34.32; C(â), 25.12; (CH2)m, 30.41; ω CH3, 14.18 (31P NMR 2.22
ppm). High-resolution FAB MS (MH+) (theoretical ) 918.7099,
observed ) 918.7169).
1
1
Bis-(2,3-myristoyl)-1-methoxy-5-hydroxy-ribose, 7. 2 (1.22 g, 7.46
mmol), myristic acid (5.45 g, 23.86 mmol), DMAP (2.92 g, 23.86
mmol), and DCC (4.93 g, 23.86 mmol) were stirred in 150 mL of DMF
for 48 h at 60 °C to afford 6. The solution was filtered, and the resultant
mixture was purified on a silica gel column with the eluent of 9/1 Hex/
EtAc. Next, the solid was immediately dissolved in aqueous acetic acid
and stirred at 50 °C for 12 h. The product, 7, was subsequently purified
by silica gel column chromotography (eluent 7/3 Hex /EtAc) with an
1
overall yield of 49% for the two steps (2.12 g, 3.63 mmol). H NMR
(CDCl3, 400 MHz, ppm): H(3), 5.339 (1H, t); H(2), 5.233 (1H, d);
H(1), 4.888 (1H, s); H(4), 4.196 (1H, m); H(5), 3.863 (2H, m); OMe,
3.413 (3H, s); H(R), 2.331 (m); H(â), 1.610 (m); (CH2)m, 1.260 (m);
ω CH3, 0.863 (t).
Bis-(2,3-myristoyl)-1-methoxy-5-(phosphocholine)-ribose, 8. Com-
pound 8 was prepared by first reacting 7 (0.64 g, 1.09 mmol) with
2-cyanoethyl-N,N ′-diisopropylchlorophosphoramidite (0.37 mL, 1.64
mmol) and DIPEA (0.33 mL, 1.86 mmol) in 60 mL of dry CH2Cl2 at
0 °C. The reaction was stirred for 2 h at 22 °C under N2. This reaction
mixture was then quenched with 2 mL of MeOH, and then the solvent
was removed by high vacuum. The mixture was dissolved in distilled
CH2Cl2, and then washed with 5% NaHCO3 and water before being
dried with Na2SO4. Dried choline chloride (0.20 g, 1.42 mmol) was
added to the reaction vessel. Next, the resultant mixture was dissolved
in 100 mL of dry CH3CN containing tetrazole (0.10 g, 1.42 mmol),
and then stirred for 7 h. An oxidizing solution of 0.2 M I2 in THF/
Pyr/H2O was added with stirring until the solution remained yellow
indicating that the phosphorus was fully oxidized, yielding the
cyanoethyl protected intermediate. This mixture was again evaporated
and azeotroped with benzene. To remove the cyanoethyl protecting
group, the contents of the reaction vessel were dissolved in 0.134 M
(aq) TEA and stirred for 3 h at room temperature. The TEA was
removed with high vacuum, and the water was removed by lyophiliza-
tion. The crude product was purified by alumina column chromatog-
raphy (72/28 CHCl3/MeOH - 69/27/4 CHCl3/MeOH/H2O), by Sepha-
dex G-10 size exclusion chromatography (50/50 CHCl3/MeOH),
followed by C-18 Sep Pak chromatography (10/90 MeOH/CHCl3).
Compound 8 (0.18 g, 0.25 mmol) was obtained in 22.4% yield for the
last three steps d-f. 2-D COSY and HMQC spectrum were performed
Acknowledgment. This work was supported by the North
Carolina Biotechnology Center (M.W.G.), the American Heart
Association (M.W.G.), the Pharmaceutical Sciences NIH Train-
ing Grant (G.S.H.), NIH grant GM27278 (T.J.M.), and Duke
1
1
to assign the resonances observed in the H NMR spectra. H NMR
(CD3CN, 400 MHz, ppm): H(3), 5.209 (1H, t, J ) 31.2 Hz); H(2),
5.120 (1H, dd, J ) 2.2 Hz); H(1), 4.870 (1H, d, J ) 0.8 Hz); H(4),
9
J. AM. CHEM. SOC. VOL. 124, NO. 21, 2002 5991